← Back to Clinical Trials
Recruiting NCT07775495

NCT07775495 Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07775495
Status Recruiting
Phase —
Sponsor Ecotera Health LLC
Condition Healthy Adult Participants
Study Type OBSERVATIONAL
Enrollment 15 participants
Start Date 2026-10-21
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 15 participants in total. It began in 2026-10-21 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to evaluate the feasibility and usability of at-home urine sample collection, preparation, and smartphone imaging using the EcoExposure™ platform in adults. The main questions it aims to answer are: Can participants successfully collect, prepare, and photograph urine samples at home and upload the images using a smartphone app? How consistent is image quality and participant adherence across repeated sampling over approximately 12 weeks? What is the short-term day-to-day variability in optical signals during an intensive daily sampling period? Participants will: Complete electronic consent and a brief intake questionnaire Collect and prepare urine samples at home at scheduled timepoints Capture guided smartphone photographs of the prepared samples Upload the images and provide brief feedback through the TrialKit app Optionally add a small reference solution (spike sample) to one sample for technical evaluation only The study is fully remote and lasts approximately 12 weeks. It is intended for product development and workflow validation purposes only and does not involve any diagnostic or clinical decision-making.

Eligibility Criteria

Inclusion Criteria: * Adults aged 18 years or older * Able to provide electronic informed consent * Willing and able to collect and prepare urine samples at home according to study instructions * Own a smartphone capable of running the TrialKit application and capturing photographs * Willing to complete the required study visits over approximately 12 weeks Exclusion Criteria: * Unable or unwilling to perform the study procedures (urine collection, sample preparation, smartphone imaging, and data upload) * Any condition or circumstance that, in the judgment of the investigator, would prevent the participant from successfully completing the study protocol

Contact & Investigator

Central Contact

Cameron Y. Research Coordinator, M. Phil

✉ hello@ecoterahealth.com

📞 +15132787420

Principal Investigator

Melinda B. Chu, M.D. M.B.A.

STUDY DIRECTOR

Ecotera Health LLC

Frequently Asked Questions

Who can join the NCT07775495 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Healthy Adult Participants. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07775495 currently recruiting?

Yes, NCT07775495 is actively recruiting participants. Contact the research team at hello@ecoterahealth.com for enrollment information.

Where is the NCT07775495 trial being conducted?

This trial is being conducted at Birmingham, United States, Anchorage, United States, Phoenix, United States, Little Rock, United States and 11 additional locations.

Who is sponsoring the NCT07775495 clinical trial?

NCT07775495 is sponsored by Ecotera Health LLC. The principal investigator is Melinda B. Chu, M.D. M.B.A. at Ecotera Health LLC. The trial plans to enroll 15 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology